A Breast Cancer Diary copertina

A Breast Cancer Diary

A Breast Cancer Diary

Di: Kathleen Moss
Ascolta gratuitamente

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
A Breast Cancer Diary is a deeply personal podcast where women tell the stories of breakthroughs, connections and paths to overcoming the challenges of Breast Cancer. It's for women who are facing decisions in the near future, as well as those who remain in this world years after diagnosis. It explores themes of body positivity, reframing of family, relationships, lifestyle, work, and it also explores recurrence, metastasis and the sacrifices that we don't normally talk about.2024 Igiene e vita sana Psicologia Psicologia e salute mentale Scienze sociali
  • Tools for Survivorship with Dr. Elenora Teplinsky
    Sep 27 2026

    I'm back for a short season interviewing my personal favorite oncologist friends... the first of which has published a wonderful book that goes on sale today! I'm sure you've heard of Dr. Teplinsky if you've been on the breast cancer end of Instagram. She's an amazing collaborator with some really wise doctors who are trying to broaden lifestyle limits that most of us breast cancer patients and survivors encounter every day--things like dry skin, brittle bones, stiff joints, and incontinance. Most oncologists don't even speak to these post menopausal and hormone blocker symptoms, but Dr. T has an amazing toolbox full of suggestions and her book is a great summary of them all. I hope you'll enjoy learning from her here.

    We talk about: the Wisdom Study for those at higher risk, the safe use of estrogen and other supplemental hormone precursers like DHEA and Testosterone, the dangers of alcohol use before and after cancer, and the new ways that AI, in its current basic form, has shown to be promising for breast cancer science.

    Even though Elenora is an oncoloist--she's not YOUR oncologist, so don't take her or my words as medical advice please!

    - Related Videos:

    The youtube playlist of both of my first two podcast seasons: https://www.youtube.com/playlist?list=PL6UwzXU_5wZHEnUiAVtorqEsWpcYTBDpC

    - Links:

    Find the new book here:

    https://interludecancerstories.com/book/

    Did you know that I'm on substack? My publications there are at https://abreastcancerdiary.substack.com

    The land where I recorded this video was once Kalapooia Tribal land. Join me by contributing to and learning from your own local indigenous farms here: https://www.soulfirefarm.org/get-involved/reparations/

    Mostra di più Mostra meno
    54 min
  • Season Two Finale on ACTIVISM
    Jun 14 2025
    I'd hoped to make season two an even 20 episodes again, but there's more important work to be done right now.... Transcript: Well, I had hoped to have three more episodes before closing for the summer, but I had a long month and a half off after my dad's passing, and I didn't get back on until last, uh, two weeks ago. And in the meantime, our country seems to be in quite a bit of turmoil. Our world seems to be in quite a bit of turmoil and I don't feel comfortable kind of moving merrily along on my path, just ignoring that at this point in time. I've always been an activist, at least at heart. I have only been an activist actively since I was about 30, when I adopted my daughter, but. I think I was meant to be an activist 'cause I picked it up and ran with it. And, uh, so I feel like that's where I need to pour my efforts right now. A lot of heartbreaking things going on in our country. A lot of shock and awe, which is just part of the plan with this administration, but also just legitimate, heartbreaking. Things happening. A US center senator in California was thrown to the ground by the FBI in his own federal building in his own state after having been invited there by the feds. And, it just seems particularly interesting that they invited him there and provoked him to speak and, um, speak the truth and then threw him to the ground and handcuffed him. That I just can't get over that, that is like so rattling to me that I can't talk about anything else right now. And today I'm recording on Saturday, the day before this is going live. And today is No King's Day, otherwise known as Trump's birthday and, Flag Day and the 250th anniversary of the military or the army. A lot of things today. It's a, it's a very momentous day and I've already been to one demonstration and I'm headed out in an hour to go to another one. And that's what's giving me life right now. I can't even talk about breast cancer advocacy because I've gotta get out in the streets and do the thing that brings me hope. Um, but I wanted to share, for those of you who are intentionally ignoring the news the way that I did up until a few months ago, I wanted to share some of the things I've been learning. That do affect us in all of this as breast cancer survivors and patients. And I think the most upsetting thing to me is this, um, what they're calling the big beautiful bill in Congress and, um, all of the damage it will do to Medicare and Medicaid patients. We've already seen a lot of our breast cancer research funds go away. They're gonna be going away permanently in the fall, but they're starting to dwindle already now. And I, I would encourage you to not give up on breast cancer research and do what you can to contribute to research through organizations like the Breast Cancer Research Foundation and Komen and other local research, uh, providers so that we can keep as many scientists in our country as possible because a lot of them are already leaving for Europe, where they'll be paid to do what they're good at. But I also wanna talk about the VA. Uh, the fact that VA is slated to lose 83,000 employees and the VA already serves breast cancer patients really poorly right now, they are stretched thin on the budget that they have right now. And so just imagine 83,000 employees going away Our veterans who, largely because of their service in the military, are being exposed to the toxins that cause breast cancer are going to be left out in the rain, out in the cold and not served sufficiently at all. And that is really tragic to me. I did wanna say one thing that I was hoping to say in this episode, the episode that followed my interview with Nanette. Uh, before I go for the summer, I wanna say, uh, there was a reference in my interview with Nanette where I kind of was shocked and showed my shock very candidly. And, um, that was because I had just read, a review of, of trial, of studies, making it clear that CT scans are extremely dangerous for us cancer patients and for people in general, especially when they're performed over and over again in close proximity, like within a year of each other. So I was really shocked to hear that she got regular CT scans as a part of her trial, and I think that's pretty common. Trials are there to see if drugs are working, and the way to see if drugs are working is scans. Um, and CT scans are among the best. And so of course trials are gonna be set up and designed to require a lot of scans. I think. It's really hopeful to me that, um, we still have some research money here in the US for breast cancer and the research money that we do have still here in the US is the kind that, requires things like patient involvement in studies. And I just became a patient advocate on a, on a study myself that hasn't been funded yet. Hopefully it will be funded, but it's, it's in the application process for funding. Going to a different source than the national, the federal funding that's been ...
    Mostra di più Mostra meno
    15 min
  • Yoga for Breast Cancer with Nanette Labastida
    Jun 1 2025
    My colleague and friend Nanette has been leading yoga for breast cancer survivors for the past few years in her community of Austin Texas, even as she's navigated the tough journey of recurrent metastatic disease in her bones. I think you'll love her spirit as she shares her story... Link to yoga4cancer: https://yoga4cancer.com/ Transcript: Today's guest is Nanette Labastida. She's in Austin, Texas, and she and I have been ambassadors together for Stand Tall AFC over the years. She is a realtor by trade, and her passion is yoga, which we'll talk about at the end of the interview. But I want to start out by asking Nanette about her background, diagnosis, and current, uh, treatment plans. Welcome Nanette. Hi, I am so excited to be here and chat with you. So yeah my history, my background diagnosis, I was originally diagnosed in 2010. I was 42, um, with breast cancer and it, it was--back then I didn't really pay that much attention to the words-- but I do know that it was ER/PR positive and HER2 negative. And I had chemo, like four rounds of chemo, no radiation. Um, and I had a mastectomy with implants, you know, with, uh, expanders and then implants. And I did tamoxifen for four years. and then in 2019 I explanted to flat. And so that's when I joined that community. It wasn't necessarily through any. um, implant illness Um, it was more like discomfort and never feeling like myself and knowing that at some point they'd need to be changed out and I'd rather not. I had the ability to do it timing wise and insurance wise--zero regrets. And then in 2022, um, I was diagnosed with, uh, stage four metastatic breast cancer. Um, so it was a recurrence, with mets to few spots in my bones, rib pelvis, and a couple on my spine. I think, um, a collarbone lymph node here, which is really the thing that got me into the oncologist. Thank goodness. And pleural effusion around my lungs. Uh oh. And then I started, uh, treatment at that time I was actually qualified for a, a clinical trial. My doctors did some research immediately and just based on like all the factors of my previous treatment and the type of cancer, all the stuff I, I entered this trial called the Serena--I might not remember the exact name of the trial, but the trial was a blind trial in which I was taking (a CDK4/6) Ibrance, taking two other pills. One was. Anastrozole. The other pill was a new drug called "SERD," or a placebo. So I would take both of them not knowing if I was getting which med I was getting. So I was getting treatment, I just didn't know which one. Okay. And it turned out in the end. Now, you just recently found out, uh, that you were on the blind arm of the trial, which means you were only taking a CDK4/6 inhibitor. It turns out I was not taking the SERD, the new trial drug, which was the blinded. So I was taking anastrozole, so I was on what I'd have been on if I wasn't on the trial, like the standard is like almost everybody or you know, a lot of people, they just do the, the CDK4/6 inhibitor and the AI and that's what I ended up being on for three years, almost three years. I didn't get the trial drug, which I've heard that it might be out later this year--a SERD on the market--an oral SERD. It's, it's, I think you had someone recently talking about fluvestrant and that's a SERD. Um, so it's kind of less, less quality of life and, and they all work a little differently anyway... For the sake of listeners who don't know what a SERD is, um, I personally got it mixed up with SERM, which is very similar. So there's selective estrogen receptor modulator. Or a SERD is the newer drug, which is a selective estrogen receptor disruptor. I believe those are the words. Degrader. Degrader, okay. Thank you. So it's, it's actually degrading the receptor site so that the receptor can't receive estrogen, right? Is that the mechanism? That's the mechanism, and so it's similar to an AI's to an aromatase inhibitor, but from a different like angle is what I understand. Well, it's similar to Tamoxifen, I think. Tamoxifen is a SERM where it's a, um, modulator, so it'll, it'll block the receptor so a SERM sits in the receptor and blocks it from receiving any oth other estrogens where a degrader, I think destroys the actual receptor. I love talking about the science. I, uh, I, I'm learning more and more, you know, especially 'cause I'm sort of such in the depths of it. And I also, like last year, attended the San Antonio Breast Cancer Symposium, um, as a patient advocate. And it, I, I'm so glad I did in this progression because I am so aware now you know, and I can bring them up to my doctor. It was. It I thought it was like too much information, but there's definitely some that like settled. Awesome. Yeah, me too. I'm, I'm hooked. Yeah. Okay. So tell us about what happened. So you had Mets in 22. Okay. That's when you started the trial right away, when you started with your diagnosis of Mets. So that's three years ago. And then just this year in 2025,...
    Mostra di più Mostra meno
    51 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione